Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation

Microvascular Research

Volumn 81, Issue 1, 2011, Pages 143-150

  Cui, Bin ^a   Huang, Lan ^a   Fang, Yuqiang ^b   Guo, Reiwei ^a   Yin, Yangguang ^a   Zhao, Xiaohui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endothelium dependent vasodilatation; Neointima; Nitric oxide; Stem cell; Transplantation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; RETROVIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; GENE OVEREXPRESSION; GENE TRANSFER; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARGININE; BALLOON DILATION; BONE MARROW CELLS; CAROTID ARTERY INJURIES; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; HYPERPLASIA; LIPOPROTEINS, LDL; MALE; NEOINTIMA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PLANT LECTINS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFECTION; VASODILATION; VON WILLEBRAND FACTOR;

RATTUS;

EID: 78650794625     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.09.009     Document Type: Article

References (30)

1. Asahara T., Murohara T., Sullivan A., Silver M., van-der-Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Carmeliet P., Moons L., Stassen J.M., De-Mol M., Bouche A., van-den-Oord J.J., Kockx M., Collen D. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am. J. Pathol. 1997, 150:761-776.
3. Cui B., Huang L., Wu X.J., Zhou Y.P., Zhang Y. Intravenous transfusion of endothelial progenitor cells reduces neointima formation. Chin. J. Pathophysiol. 2007, 23:625-628.
4. Dimmeler S., Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?. J. Mol. Med. 2004, 82:671-677.
5. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., Zeiher A.M. HMG-CoA reductase inhibitors increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 2001, 108:391-397.
6. d'Uscio L.V., Smith L.A., Santhanam A.V., Richardson D., Nath K.A., Katusic Z.S. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 2007, 49:1142-1148.
7. Giachini F.R., Carneiro F.S., Lima V.V., Carneiro Z.N., Dorrance A., Webb R.C., Tostes R.C. Upregulation of intermediate calcium-activated potassium channels counterbalance the impaired endothelium-dependent vasodilatation in stroke-prone spontaneously hypertensive rats. Transl. Res. 2009, 154(4):183-193.
8. Griese D.P., Ehsan A., Melo L.G., Kong D., Zhang L., Mann M.J., Pratt R.E., Mulligan R.C., Dzau V.J. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003, 108:2710-2715.
9. Hill J.M., Zaloss G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
10. Ignarro L.J., Napoli C., Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ. Res. 2002, 90:21-28.
11. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., Isner J.M., Asahara T., Losordo D.W. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003, 108:3115-3121.
12. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3422-3427.
13. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., Silver M., Ma H., Kearney M., Isner J.M., Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
14. Kong D., Melo L.G., Mangi A.A., Zhang L., Lopez-Ilasaca M., Perrella M.A., Liew C.C., Pratt R.E., Dzau V.J. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 13:1769-1775.
15. Krenning G., van-Luyn M.J., Harmsen M.C. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol. Med. 2009, 15(4):180-189.
16. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003, 111:1201-1209.
17. Landmesser U., Engberding N., Bahlmann F.H., Schaefer A., Wiencke A., Heineke A., Spiekermann S., Hilfiker-Kleiner D., Templin C., Kotlarz D., Mueller M., Fuchs M., Hornig B., Haller H., Drexler H. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004, 110:1933-1939.
18. Ma F.X., Zhou B., Chen Z., Ren Q., Lu S.H., Sawamura T., Han Z.C. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J. Lipid Res. 2006, 47:1227-1237.
19. Sambuceti G., Morbelli S., Vanella L., Kusmic C., Marini C., Massollo M., Augeri C., Corselli M., Ghersi C., Chiavarina B., Rodella L.F., L'Abbate A., Drummond G., Abraham N.G., Frassoni F. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 2009, 27(2):399-407.
20. Schroeter M.R., Leifheit M., Sudholt P., Heida N.M., Dellas C., Rohm I., Alves F., Zientkowska M., Rafail S., Puls M., Hasenfuss G., Konstantinides S., Schafer K. Leptin Enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting intergrin-mediated adhesion. Circ. Res. 2008, 103:536-544.
21. Song M.B., Yu X.J., Zhu G.X., Chen J.F., Zhao G., Huang L. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Vascul. Pharmacol. 2009, 51(2-3):205-213.
22. Subodh Verma, Michael A., Kuliszewski B.S., Szmitko P.E., Zucco L., Wang C.H., Badiwala M.V., Mickle D.A., Weisel R.D., Fedak P.W., Stewart D.J., Kutryk M.J. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function. Circulation 2004, 109:2058-2067.
23. Tulis D.A., Mnjoyan Z.H., Schiesser R.L., Schiesser R.L., Shelat H.S., Evans A.J., Zoldhelyi P., Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation 2003, 107:98-105.
24. Urao N., Okigaki M., Yamada H., Aadachi Y., Matsuno K., Matsui A., Matsunaga S., Tateishi K., Nomura T., Takahashi T., Tatsumi T., Matsubara H. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ. Res. 2006, 98:1405-1413.
25. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cir. Res. 2001, 89:e1-e7.
26. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D.W., Asahara T., Isner J.M. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
27. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 2003, 93:e17-e24.
28. Wu X.J., Zhou Q., Huang L., Sun A.J., Wang K.Q., Zou Y.Z., Ge J.B. Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells. Cardiovasc. Res. 2008, 77:800-808.
29. Zhao Yidan D., Courtman David W., Deng Yupu, Kugathasan Lakshmi, Zhang Qiuwang, Stewart Duncan J. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ. Res. 2005, 96:442-450.
30. Zhao X.H., Huang L., Yin Y.G., Fang Y.Q., Zhou Y.P. Autologous endothelial progenitor cells transplantation promoting endothelial recovery in mice. Transplant. Int. 2007, 20:712-721.